美国最大制药公司分别按照年收入和市值排名,其差异应该对选股有帮助:

本帖于 2025-05-08 17:54:44 时间, 由普通用户 BigMountain6 编辑

所有跟帖: 

有意思。谢谢分享。市值和收入不成正比有很多因素。 -gastank1289- 给 gastank1289 发送悄悄话 (162 bytes) () 05/08/2025 postreply 17:44:10

What if using TTM revenue? Or even better FTM rev estimate? -三心三意- 给 三心三意 发送悄悄话 三心三意 的博客首页 (0 bytes) () 05/08/2025 postreply 18:10:06

Certainly FTM works better, however -BigMountain6- 给 BigMountain6 发送悄悄话 (115 bytes) () 05/08/2025 postreply 19:26:22

That should be reflected in revenue, margin, and earning -三心三意- 给 三心三意 发送悄悄话 三心三意 的博客首页 (155 bytes) () 05/08/2025 postreply 19:34:45

Indicator PEG is definitely excellent, but difficult to be ~ -BigMountain6- 给 BigMountain6 发送悄悄话 (114 bytes) () 05/09/2025 postreply 05:23:13

PFE's 5 years expected PEG is 0.58 vs. LLY 1.12. -ht842- 给 ht842 发送悄悄话 (36 bytes) () 05/09/2025 postreply 05:38:13

请您先登陆,再发跟帖!